Table 1 |
||||
|
Subject randomization |
||||
|
Group |
Name |
Sample size |
Compound |
Dosage |
|
|
||||
|
A0 |
Placebo |
n = 15 |
Placebo |
N/A (CMC capsule b.i.d) |
|
A1 |
Dose 1 |
n = 15 |
UP446 |
250 mg/day (125 mg b.i.d.) |
|
A2 |
Dose 2 |
n = 15 |
UP446 |
500 mg/day (250 mg b.i.d.) |
|
A3 |
Dose 3 |
n = 15 |
Celecoxib |
200 mg/day (100 mg b.i.d.) |
|
|
||||
|
Acetaminophen was provided as rescue medication. Subjects were permitted to take up to 1000 mg t.i.d. |
||||
|
Sampalis and Brownell Nutrition Journal 2012 11:21 doi:10.1186/1475-2891-11-21 |
||||
